This bill aims to strengthen oversight and accountability at the Center for Medicare and Medicaid Innovation, which tests new healthcare payment and service delivery models. The legislation limits initial testing phases to no more than five years and restricts them to either ten percent of eligible beneficiaries or 500,000 beneficiaries, whichever is smaller, while capping the center at launching no more than six new Phase 1 models per fiscal year. The bill requires the center to establish hardship waivers for providers facing economic difficulties, continuously monitor real-time impacts on patients, and provide public notice with at least 45 days for stakeholder feedback before implementing major model changes. Additionally, the bill creates a congressional review mechanism allowing either house to block model expansions within 45 days using expedited procedures, while also reestablishing limited judicial review to ensure protections for Medicare beneficiaries. The legislation takes effect January 1, 2024, with certain provisions like the hardship waiver plan required to be implemented within 60 days of enactment.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.